z-logo
open-access-imgOpen Access
Functional cross-talk between phosphorylation and disease-causing mutations in the cardiac sodium channel Na v 1.5
Author(s) -
Iacopo Galleano,
Hendrik J. Harms,
Koushik Choudhury,
Keith K. Khoo,
Lucie Delemotte,
Stephan A. Pless
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2025320118
Subject(s) - phosphorylation , mutation , tyrosine phosphorylation , sodium channel , heartbeat , tyrosine , microbiology and biotechnology , biology , sodium , chemistry , medicine , endocrinology , genetics , biochemistry , gene , computer science , organic chemistry , computer security
Significance The cardiac sodium channel (Na v 1.5) is crucial for generating a regular heartbeat. It is thus not surprising that Na v 1.5 mutations have been linked to life-threatening arrhythmias. Interestingly, Na v 1.5 activity can also be altered by posttranslational modifications, such as tyrosine phosphorylation. Our combination of protein engineering and molecular modeling has revealed that the detrimental effect of a long QT3 patient mutation is only exposed when a proximal tyrosine is phosphorylated. This suggests a dynamic cross-talk between the genetic mutation and a neighboring phosphorylation, a phenomenon that could be important in other classes of proteins. Additionally, we show that phosphorylation can affect the channel’s sensitivity toward clinically relevant drugs, a finding that may prove important when devising patient-specific treatment plans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom